Less Ads, More Data, More Tools Register for FREE

Pin to quick picksKainos Group Regulatory News (KNOS)

Share Price Information for Kainos Group (KNOS)

Share Price is delayed by 15 minutes
Get Live Data
775.50    -16.00 (-2.02%)
Bid:
771.00
Ask:
775.00
Spread: 4.00 (0.519%)
Market Cap: £893.17m
KNOS Live PriceLast checked at - London Stock Exchange

Intraday Kainos Group Share Chart

Board and Board Committee Changes

20 May 2024 07:01

RNS Number : 0030P
Kainos Group plc
20 May 2024
 

20 May 2024

 

Kainos Group plc

("Kainos" or the "Company") 

 

Board and Board Committee Changes

Kainos Group plc (KNOS), a UK-headquartered provider of sophisticated IT services with expertise across three divisions: Digital Services, Workday Services, and Workday Products, today announces the following Board and Board Committee changes:

- Tom Burnet, Independent Non-Executive Director, Board Chair and Chair of the Nominations Committee, will complete his term on the Board following the Company's Annual General Meeting on 24 September 2024.

- Andy Malpass, Independent Non-Executive Director, Senior Independent Director and Chair of the Audit Committee will complete his term on the Board after the Company's Annual General Meeting on 24 September 2024. Andy will step down as Chair of the Audit Committee with effect from 01 June 2024 but will remain a member of the Audit Committee until the conclusion of the Company's Annual General Meeting on 24 September 2024.

- Rosaleen Blair, Independent Non-Executive Director, member of the Nominations Committee, member of the Audit Committee and member of the Remuneration Committee will succeed Tom as the new Board Chair and Chair of the Nominations Committee, with effect from the conclusion of the Company's Annual General Meeting on 24 September 2024. At this time, in compliance with the Corporate Governance Code, Rosaleen will step down as a member of the Audit Committee.

- James Kidd Independent Non-Executive Director, member of the Audit Committee and member of the Remuneration Committee will assume the role of Chair of the Audit Committee with effect from 01 June 2024 and with effect from the conclusion of the Company's Annual General Meeting on 24 September 2024will assume the role of Senior Independent Director, succeeding Andy and will become a member of the Nominations Committee

Russell Sloan, CEO commented on the changes:

"Our AGM later this year will mark the completion of Tom and Andy's term on our Board. Tom and Andy were both appointed Non-Executive Directors at our IPO in 2015 and over the past nine years have been instrumental in establishing Kainos as a leading public company.

We are incredibly grateful for the energy, insight and guidance that Tom and Andy brought to the business during their time on our Board.

We are delighted that Rosaleen will be assuming the position of Board Chair and James' market experience makes him ideally placed for the role of Senior Independent Director."

This notification is made pursuant to Listing Rule 9.6.11.

Kainos Group plc Legal Entity Identifier: 213800H2PQMIF3OVZY47 

Regulated Information Classification: 3.1 - Additional regulated information.

 

Ends

 

For further information, please contact:

 

Kainos via FTI Consulting LLP

Russell Sloan, Chief Executive Officer

Richard McCann, Chief Financial Officer

 

Investec Bank plc +44 20 7597 5970

Patrick Robb / Ben Griffiths / Nick Prowting

 

FTI Consulting LLP +44 20 3727 1000

Dwight Burden / Kwaku Aning / Usama Ali

 

About Kainos

Kainos Group plc is a UK-headquartered provider of sophisticated IT services to major public sector, commercial and healthcare customers. Our expertise spans three divisions: Digital Services, Workday Services, and Workday Products.

 

Digital Services: We develop and support custom digital service platforms that transform service delivery in public, commercial, and healthcare sectors. Our solutions ensure security, accessibility, cost-effectiveness, and improved user outcomes.

 

Workday Services: Specialising in deploying Workday, Inc.'s Finance, HR, and Planning products, we are a respected partner in Europe and North America. Experienced in complex deployments, we are trusted to launch, test, expand, and support Workday systems.

 

Workday Products: Our established product suite, incorporating Smart Test, Smart Audit, and Smart Shield, complements Workday by enhancing system security and compliance. Our Employee Document Management product, launched in October 2023, improves document generation and storage within Workday while supporting global compliance requirements. Over 450 global customers use one or more of our products.

 

Our people are central to our success. We have more than 2,900 people in 23 countries across Europe, Asia, and the Americas.

 

We are listed on the London Stock Exchange (LSE: KNOS) and you can discover more about us at www.kainos.com.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAEAKSNFFSLEFA
Date   Source Headline
18th Nov 20247:00 amRNSTransaction in Own Shares
15th Nov 20247:00 amRNSTransaction in Own Shares
13th Nov 20247:00 amRNSTransaction in Own Shares
12th Nov 202412:32 pmRNSDirector / PDMR shareholdings
11th Nov 20247:01 amRNSShare buyback programme
11th Nov 20247:00 amRNSInterim Results
31st Oct 20247:00 amRNSTrading Update
1st Oct 20249:49 amRNSTotal Voting Rights
24th Sep 20241:11 pmRNSBoard Changes
24th Sep 20241:06 pmRNSResults of Annual General Meeting
9th Sep 202410:14 amRNSHolding(s) in Company
2nd Sep 202411:13 amRNSTotal Voting Rights
2nd Sep 20247:00 amRNSTrading Statement
15th Aug 202410:00 amRNSNotice of AGM
1st Aug 202410:34 amRNSTotal Voting Rights
31st Jul 20244:41 pmRNSAnnual Report 2024
25th Jul 20242:30 pmRNSWorkday Partnership & Co-Sell drives £200m Target
11th Jul 202410:26 amRNSTR-1: Notification of major holdings
2nd Jul 20249:57 amRNSDirector / PDMR shareholdings
1st Jul 20249:23 amRNSTotal Voting Rights
3rd Jun 20243:53 pmRNSDirector/PDMR Shareholding
3rd Jun 202410:36 amRNSTotal Voting Rights
20th May 20247:01 amRNSBoard and Board Committee Changes
20th May 20247:00 amRNSFull year results
1st May 202412:00 pmRNSTotal Voting Rights
15th Apr 20247:00 amRNSYear-end Trading Update
11th Apr 20243:50 pmRNSHolding(s) in Company
2nd Apr 202412:12 pmRNSTotal Voting Rights
15th Mar 20241:48 pmRNSHolding(s) in Company
28th Feb 20243:16 pmRNSHolding(s) in Company
5th Feb 202412:51 pmRNSHolding(s) in Company
1st Feb 20244:29 pmRNSHolding(s) in Company
1st Feb 20244:21 pmRNSHolding(s) in Company
1st Feb 202412:13 pmRNSTotal Voting Rights
31st Jan 20244:09 pmRNSDirector/PDMR Shareholding
2nd Jan 202412:15 pmRNSTotal Voting Rights
22nd Dec 20239:21 amRNSExecutive Director PSP Award/PDMR shareholdings
1st Dec 20239:35 amRNSTotal Voting Rights
17th Nov 202311:13 amRNSExecutive Director PSP Award/PDMR shareholdings
13th Nov 20237:00 amRNSInterim Results
1st Nov 202310:48 amRNSTotal Voting Rights
2nd Oct 202312:41 pmRNSTotal Voting Rights
2nd Oct 20237:00 amRNSConfirmation of Board Changes
27th Sep 20235:52 pmRNSDirector/PDMR Shareholding
21st Sep 20232:54 pmRNSResults of Annual General Meeting
21st Sep 202311:59 amRNSConfirmation of CEO appointment
1st Sep 202312:34 pmRNSTotal Voting Rights
31st Aug 20237:00 amRNSTrading Update
10th Aug 20232:48 pmRNSNotice of AGM
3rd Aug 202310:41 amRNSMount Charles & Bankmore Square, Belfast

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.